Top

Published in:

01-08-2012 | PSORIATIC ARTHRITIS (O FITZGERALD AND P HELLIWELL, SECTION EDITORS)

Impact of Psoriatic Arthritis on the Patient: Through the Lens of the WHO International Classification of Functioning, Health, and Disability

Author: William J. Taylor

Published in: Current Rheumatology Reports | Issue 4/2012

Abstract

Psoriatic arthritis is associated with a broad range of problems from the perspective of the patient. These include symptoms relating to skin and musculoskeletal disease to difficulties with day-to-day activities, social interactions, paid employment, and community participation. Additional problems related to frequent comorbidities impose further impact. It has been shown that individuals with psoriatic arthritis have similar or worse disability than men older than 75 years of age in the general population, and psoriatic arthritis confers worse health status than many other common chronic diseases. The World Health Organization International Classification of Functioning, Disability, and Health provides a useful framework for considering the impact of this disease. Ideal clinical management of psoriatic arthritis would provide access to an interdisciplinary team with expertise in functional, social, vocational, and community issues, as well as to medical expertise.

Sanderson T, Kirwan J. Patient-reported outcomes for arthritis: time to focus on personal life impact measures? Arthritis Rheum. 2009;61(1):1–3.PubMedCrossRef

World Health Organization. International classification of functioning, disability and health: ICF: WHO; 2001.

Taylor WJ, Gladman DD, Mease PJ, Adebajo A, Nash P, Feletar M. The impact of psoriatic arthritis (PsA) according to the International Classification of Functioning, Health and Disability (ICF). J Rheumatol. 2010;37:1885–91.PubMedCrossRef

Leung YY, Ho KW, Zhu TY, Tam LS, Kun EW, Li EK. Testing scaling assumptions, reliability and validity of Medical Outcomes Study Short-Form 36 health survey in psoriatic arthritis. Rheumatology (Oxford). 2010;49(8):1495–501.CrossRef

Ware JE, Kosinski M, Bjorner JB, Turner, Bowker DM, Gandek B, et al. User’s manual for the SF-36v2 Health Survey. 2nd edition ed. Lincoln, RI: QualityMetric Incorporated; 2007.

Stamm TA, Nell V, Mathis M, Coenen M, Aletaha D, Cieza A, et al. Concepts important to people with psoriatic arthritis are not adequately covered by standard measures of functioning. Arthritis Rheum (Arthritis Care Res). 2007;57(3):487–94.CrossRef

Uttjek M, Nygren L, Stenberg B, Dufaker M. Marked by visibility of psoriasis in everyday life. Qual Health Res. 2007;17(3):364–72.PubMedCrossRef

Feldman S, Behnam SM, Behnam SE, Koo JYM. Involving the patient: impact of inflammatory skin disease and patient-focused care. J Am Acad Dermatol. 2005;53:S78–85.PubMedCrossRef

Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139(5):846–50.PubMedCrossRef

10.

Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol. 1995;132:236–44.PubMedCrossRef

11.

Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcome. 2009;7:25.CrossRef

12.

•• Wallenius M, Skomsvoll JF, Koldingsnes W, Rodevand E, Mikkelsen K, Kaufmann C, et al. Work disability and health-related quality of life in males and females with psoriatic arthritis. Ann Rheum Dis. 2009;68:685–9. This was the first study to document the extent of work disability in people with PsA; it showed that a large percentage of people with PsA aged 18 to 45 years are work disabled. In this population, work disability was mainly associated with physical disability, level of education, and female sex.PubMedCrossRef

13.

Ciocon DH, Horn EJ, Kimball AB. Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only: results of the 2005 Spring US National Psoriasis Foundation Survey. Am J Clin Dermatol. 2008;9(2):111–7.PubMedCrossRef

14.

Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol. 2000;80(6):430–4.PubMedCrossRef

15.

Ruschenschmidt C, Somberg B, Haussler G, Lohmann J. Comparison of patients with psoriasis vulgaris vs. psoriatic arthritis with regard to the reported quality of life. Die Rehabilitation. 2008;47(6):343–9.PubMedCrossRef

16.

• Christophers E, Barker JN, Griffiths CE, Dauden E, Milligan G, Molta C, et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol: JEADV. 2010;24(5):548–54. This large study of patients attending dermatology outpatient clinics across Europe yielded a number of interesting findings. Of relevance to this review was the finding of considerably worse HRQoL in people with PsA compared with people with psoriasis alone.PubMedCrossRef

17.

• Hu SW, Holt EW, Husni ME, Qureshi AA. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study. Sem Arthritis Rheum. 2010;39:384–97. This novel paper determined the relative importance of several domains of well-being for people with PsA using the econometric method of willingness-to-pay. In this group, the most significant area of life was physical comfort, whereas the least significant was self-care. This approach integrates the notion of degree of the problem with the notion of personal importance of the problem and is one of only a few studies to have addressed that concept.CrossRef

18.

•• Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res. 2011;63(12):1729–35. This study was the first to adequately compare comorbidities between psoriasis and PsA and extends the range of possible comorbidities associated with PsA considerably. Depression and hypertension were common, but this study also found autoimmune, gastrointestinal, and neurological disorders to be more common in PsA patients.CrossRef

19.

Borman P, Toy GC, Babaoglu S, Bodur H, Deniz C, Alli N. A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis. Clin Rheumatol. 2007;26:330–4.PubMedCrossRef

20.

Zink A, Thiele K, Huscher D, Listing J, Sieper J, Krause A, et al. Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol. 2006;33(1):86–90.PubMed

21.

Husted JA, Gladman DD, Farewell VT, Cook RJ. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum. 2001;45(2):151–8.PubMedCrossRef

Title: Impact of Psoriatic Arthritis on the Patient: Through the Lens of the WHO International Classification of Functioning, Health, and Disability
Author: William J. Taylor
Publication date: 01-08-2012
Publisher: Current Science Inc.
Published in: Current Rheumatology Reports / Issue 4/2012
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI: https://doi.org/10.1007/s11926-012-0263-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Impact of Psoriatic Arthritis on the Patient: Through the Lens of the WHO International Classification of Functioning, Health, and Disability

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2012

Biologic Differences Between Various Inhibitors of the BLyS/BAFF Pathway: Should We Expect Differences Between Belimumab and Other Inhibitors in Development?

Cardiovascular Mortality in Psoriasis and Psoriatic Arthritis: Epidemiology, Pathomechanisms, Therapeutic Implications, and Perspectives

Data Quality Challenges in Systemic Lupus Erythematosus Trials: How Can This Be Optimized?

Belimumab Is Approved by the FDA: What More Do We Need to Know to Optimize Decision Making?

Treatment Algorithms for Early Psoriatic Arthritis: Do They Depend on Disease Phenotype?

What Have Genome-Wide Studies Told Us About Psoriatic Arthritis?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page